Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Apheresis”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT00073060
What this trial is testing

Citrate Effects and Bone Density in Long-Term Apheresis Donors

Who this might be right for
Healthy Apheresis Donors
National Institutes of Health Clinical Center (CC) 273
Testing effectiveness (Phase 2)Study completedNCT00006417
What this trial is testing

Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Large-scale testing (Phase 3)Ended earlyNCT00074763
What this trial is testing

Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 4
Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Not applicableStudy completedNCT00042627
What this trial is testing

Prevalence and Risk of Cataracts in Granulocyte Donors

Who this might be right for
Apheresis
National Eye Institute (NEI) 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT00061568
What this trial is testing

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Who this might be right for
Congenital Hemolytic AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 130
Testing effectiveness (Phase 2)Study completedNCT00001637
What this trial is testing

Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseLeukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 28
Early research (Phase 1)Study completedNCT00001842
What this trial is testing

G-CSF for Granulocyte Donation

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 16
Large-scale testing (Phase 3)Study completedNCT00005782
What this trial is testing

Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait

Who this might be right for
Sickle Cell Trait
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03077542
What this trial is testing

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 57
Not applicableStudy completedNCT03477656
What this trial is testing

Evaluation of 2 Techniques of Apheresis to Desensitize ABO Incompatible Kidney Transplant Candidates

Who this might be right for
Kidney Transplantation
University Hospital, Toulouse 30
Testing effectiveness (Phase 2)Study completedNCT00006184
What this trial is testing

Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00001765
What this trial is testing

Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)Looking for participantsNCT01553214
What this trial is testing

Improving White Blood Cell Collection From Healthy Donors

Who this might be right for
Allogeneic Granulocyte Donation
National Institutes of Health Clinical Center (CC) 1,000
Not applicableLooking for participantsNCT00001846
What this trial is testing

Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use

Who this might be right for
Blood DonorsResearch SubjectsApheresis
National Institutes of Health Clinical Center (CC) 5,000
Not applicableStudy completedNCT01901458
What this trial is testing

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®

Who this might be right for
Healthy Allogeneic DonorsGranulocyte Colony-stimulating Factor (G-CSF) Mobilized
Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)Study completedNCT00025662
What this trial is testing

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

Who this might be right for
Graft vs Host DiseaseMyelodysplastic SyndromesLeukemia+7 more
National Heart, Lung, and Blood Institute (NHLBI) 23
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Early research (Phase 1)Study completedNCT00001748
What this trial is testing

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsLymphoma+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Not applicableStudy completedNCT00001623
What this trial is testing

Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmLeukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 41
Load More Results